APA (7th ed.) Citation

Hady Yazbeck, Joe Youssef, Wassim Nasreddine, Abdullah El Kurdi, Nathalie Zgheib, & Ahmad Beydoun. (2024). The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Hady Yazbeck, Joe Youssef, Wassim Nasreddine, Abdullah El Kurdi, Nathalie Zgheib, and Ahmad Beydoun. The Role of Candidate Pharmacogenetic Variants in Determining Valproic Acid Efficacy, Toxicity and Concentrations in Patients with Epilepsy. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Hady Yazbeck, et al. The Role of Candidate Pharmacogenetic Variants in Determining Valproic Acid Efficacy, Toxicity and Concentrations in Patients with Epilepsy. Frontiers Media S.A., 2024.